Company profile for Bioxodes

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bioxodes is a visionary clinical-stage biopharmaceutical company dedicated to advancing the field of therapeutics for patients battling thrombo-inflammatory diseases. With a profound expertise in thrombotic and inflammatory processes, we lead the way in discovering and developing a new generation of innovative treatments. Our mission is to meet unmet medical needs through the creation of novel product candidates that promise t...
Bioxodes is a visionary clinical-stage biopharmaceutical company dedicated to advancing the field of therapeutics for patients battling thrombo-inflammatory diseases. With a profound expertise in thrombotic and inflammatory processes, we lead the way in discovering and developing a new generation of innovative treatments. Our mission is to meet unmet medical needs through the creation of novel product candidates that promise to redefine standards of care.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Rue Santos-Dumont, 1, Brussels South Charleroi Biopark, Gosselies, Région Wa...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/10/3202925/0/en/Bioxodes-raises-5-5-million-Series-A-extension-to-continue-preparations-for-pivotal-trial-of-breakthrough-stroke-candidate.html

GLOBENEWSWIRE
10 Dec 2025

https://www.globenewswire.com/news-release/2025/11/14/3188030/0/en/Bioxodes-presents-BIOX-101-clinical-data-showing-breakthrough-potential-for-stroke-in-webcast-with-Prof-Dr-Robin-Lemmens.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/10/07/3162233/0/en/Bioxodes-appoints-industry-veteran-Philippe-Monteyne-as-chairman-as-it-accelerates-late-stage-development-of-breakthrough-stroke-candidate.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2025/09/11/3148338/0/en/Bioxodes-positive-Phase-2a-stroke-data-show-breakthrough-potential-of-innovative-therapeutic-candidate-BIOX-101.html

GLOBENEWSWIRE
11 Sep 2025

https://www.fiercebiotech.com/biotech/bioxodes-halts-phase-2-stroke-trial-after-successful-interim-review-plots-registrational

FIERCE BIOTECH
24 Apr 2025

https://www.globenewswire.com/news-release/2025/03/05/3037134/0/en/Bioxodes-obtains-Orphan-Drug-Designation-for-hemorrhagic-stroke-therapeutic-candidate-in-US-and-Europe.html

GLOBENEWSWIRE
05 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty